Investigators indicated that 5′-Azacitidine increased the immunogenicity of acute myeloid leukemia cells, enhancing recognition and elimination of malignant cells by highly efficient CTLA-4negative anti-CD123 chimeric antigen receptor (CAR) T cells.
[Nature Communications]
7992332
BBBBBBBB
items
1
apa
0
default
asc
1
168777
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
